Suivre
Nicholas V. DiBenedetto
Nicholas V. DiBenedetto
Tufts University School of Medicine
Adresse e-mail validée de tufts.edu
Titre
Citée par
Citée par
Année
Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy
A Abdel-Gadir, E Stephen-Victor, GK Gerber, M Noval Rivas, S Wang, ...
Nature medicine 25 (7), 1164-1174, 2019
2892019
A selective gut bacterial bile salt hydrolase alters host metabolism
L Yao, SC Seaton, S Ndousse-Fetter, AA Adhikari, N DiBenedetto, ...
Elife 7, e37182, 2018
2122018
In vivo commensal control of Clostridioides difficile virulence
BP Girinathan, N DiBenedetto, JN Worley, J Peltier, ML Arrieta-Ortiz, ...
Cell Host & Microbe 29 (11), 1693-1708. e7, 2021
732021
Engineered interspecies amino acid cross-feeding increases population evenness in a synthetic bacterial consortium
M Ziesack, T Gibson, JKW Oliver, AM Shumaker, BB Hsu, DT Riglar, ...
Msystems 4 (4), 10.1128/msystems. 00352-19, 2019
452019
Gnotobiotic and conventional mouse systems to support microbiota based studies
R Lavin, N DiBenedetto, V Yeliseyev, M Delaney, L Bry
Current protocols in immunology 121 (1), e48, 2018
192018
Proanthocyanidin-enriched cranberry extract induces resilient bacterial community dynamics in a gnotobiotic mouse model
CC Neto, BM Mortzfeld, JR Turbitt, SK Bhattarai, V Yeliseyev, ...
Microbial Cell 8 (6), 131, 2021
172021
Predictive regulatory and metabolic network models for systems analysis of Clostridioides difficile
ML Arrieta-Ortiz, SRC Immanuel, S Turkarslan, WJ Wu, BP Girinathan, ...
Cell host & microbe 29 (11), 1709-1723. e5, 2021
132021
c-di-AMP signaling is required for bile salt resistance, osmotolerance, and long-term host colonization by Clostridioides difficile
M Oberkampf, A Hamiot, P Altamirano-Silva, P Bellés-Sancho, ...
Science signaling 15 (750), eabn8171, 2022
122022
Intrinsic instability of the dysbiotic microbiome revealed through dynamical systems inference at scale
TE Gibson, Y Kim, S Acharya, DE Kaplan, N DiBenedetto, R Lavin, ...
BioRxiv, 469105, 2021
102021
Engineered interspecies amino acid cross-feeding increases population evenness in a synthetic bacterial consortium. mSystems 4: e00352-19
M Ziesack, T Gibson, JKW Oliver, AM Shumaker, BB Hsu, DT Riglar, ...
PubMed, ISI, 2019
62019
Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy
A Abdel-Gadir, E Stephen-Victor, GK Gerber, MN Rivas, S Wang, H Harb, ...
Nature medicine 25 (9), 1458, 2019
42019
Engineered Interspecies Amino Acid Cross-Feeding Increases Population Evenness in a Synthetic Bacterial Consortium. mSystems. 2019; 4 (4): e00352–19
M Ziesack, T Gibson, JKW Oliver, AM Shumaker, BB Hsu, DT Riglar, ...
Licensee MDPI, Basel, Switzerland. This article is an open access article …, 0
4
The TcdE holin drives toxin secretion and virulence in Clostridioides difficile
NV DiBenedetto, M Oberkampf, L Cersosimo, V Yeliseyev, L Bry, J Peltier, ...
bioRxiv, 2023
12023
Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopy
JW Ribis, CA Nieto-Acuna, Q Dong, N DiBenedetto, A Mehra, IL Nagawa, ...
bioRxiv, 2024.02. 13.580212, 2024
2024
Defined therapeutic microbiota and methods of use thereof
L Bry, G Gerber, J Allegretti, R Lavin, N Dibenedetto
US Patent 11,666,611, 2023
2023
Clostridium scindens colonization of gnotobiotic mice promotes a chronic unresolving infection with Clostridioides difficile
M Graham, N DiBenedetto, ML Delaney, R Lavin, A Pavao, V Yeliseyev, ...
bioRxiv, 2022.06. 12.495821, 2022
2022
c-di-AMP signaling is required for bile salts resistance and long-term colonization by Clostridioides difficile
M Oberkampf, A Hamiot, P Altamirano-Silva, P Bellés-Sancho, ...
bioRxiv, 2021.08. 23.457418, 2021
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–17